Skip to main content
. 2018 Jun 1;59(9):1729–1737. doi: 10.1194/jlr.P081281

Fig. 2.

Fig. 2.

Association of plasma concentrations of Cer (d18:1/16:0) with MACE in the full cohort and in patients with ACS or SAP. The results are presented as hazard ratios (HRs) for Cer(d18:1/16:0) above versus below the median, with 95% CIs. ACS, acute coronary syndrome; Cer, ceramide; MACE, major adverse cardiac event; SAP, stable angina pectoris.